Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Giant Cell Tumor of Bone
NCT00680992Phase 2Completed
- Sponsor
- Amgen
- Start
- Sep 2008
- Primary completion
- May 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of denosumab in Giant Cell Tumor of Bone (GCTB), sponsored by Amgen. Started Sep 2008; status: completed.
02
Drugs
denosumab
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on NCT00680992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680992.